Jessica T Leonard

13PUBLICATIONS
118CO-AUTHORS
Haematological tumoursAutonomic nervous systemPhysiotherapyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 15, 2026
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.

|Jul 30, 2026
Early neurologic response predicts outcomes after anakinra for immune effector cell-associated neurotoxicity syndrome.

|Jun 25, 2026
Improved outcomes with TKI maintenance after brexucabtagene autoleucel in Philadelphia chromosome ALL.

|May 19, 2026
Consensus recommendations for CAR T-cell administration in adult acute lymphoblastic leukemia: a modified Delphi study.

|Feb 05, 2026
Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang

|Aug 23, 2025
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.

Timothy E O'Connor, Chenyu Lin, Gregory W Roloff

Pageof 3

Frequent Collaborators

7 joint publications

Aaron C Logan

7 joint publications

Lori S Muffly

6 joint publications

Joshua Sasine

6 joint publications

LaQuisa C Hill